Von Willebrand Disease in a pediatric-based population - Comparison of type 1 diagnostic criteria and use of the PFA-100® and a von Willebrand factor/Collagen-binding assay

Thrombosis and Haemostasis

Volumn 84, Issue 3, 2000, Pages 401-409

  Dean, J A ^a   Blanchette, V S ^a   Carcao, M D ^a   Stain, A M ^a   Sparling, C R ^a   Siekmann, J ^a   Turecek, P L ^a   Lillicrap, D ^a   Rand, M L ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Collagen binding activity; Pediatrics; PFA 100; Type 1 von Willebrand disease; von Willebrand disease

Indexed keywords

COLLAGEN; VON WILLEBRAND FACTOR;

ADOLESCENT; ANALYZER; ARTICLE; BINDING KINETICS; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; FUNCTION TEST; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PEDIATRICS; PLATELET FUNCTION ANALYZER; PRIORITY JOURNAL; PROTEIN BINDING; QUANTITATIVE ASSAY; SCREENING TEST; VON WILLEBRAND DISEASE;

EID: 0033828195     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614035     Document Type: Article

References (41)

1. Hereditar pseudohemofili
2. Von Willebrand factor: Structure and function
3. Von Willebrand factor
4. Epidemiological investigation of the prevalence of von Willebrand's disease
5. Prevalence of von Willebrand disease in children: A multiethnic study
6. The effect of ABO blood group on the diagnosis of von Willebrand disease
7. Von Willebrand factor is an acute phase reactant in man
8. Serial studies in von Willebrand's disease: Variability versus 'variants'
9. Genetics of classic von Willebrand's disease II. Optimal assignment of the heterozygous genotype (diagnosis) by discriminant analysis
10. Laboratory diagnosis of von Willebrand's disease
11. Genetics of classic von Willebrand's disease. I. Phenotypic variation within families
12. A revised classification of von Willebrand disease. For the Subcommittee on von Willebrand factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis
13. Laboratory assays for von Willebrand factor: Relative contribution to the diagnosis of von Willebrand's disease
14. Von Willebrand disease
15. Screening for von Willebrand disease with a new analyzer using high shear stress. A study of 60 cases
16. Evaluation of the PFA-100(®) system in the diagnosis and therapeutic monitoring of patients with von Willebrand disease
17. An ELISA test for the binding of von Willebrand antigen to collagen
18. Von Willebrand's disease: Laboratory investigation using an improved functional assay for von Willebrand factor
19. Laboratory assessment of von Willebrand factor
20. The measurement of observer agreement for categorical data
21. The complex multimeric composition of factor VIII/von Willebrand factor
22. Visualisation of von Willebrand factor multimers by immunoenzymatic stain using avidin-biotin peroxidase complex
23. The Platelet Function Analyzer (PFA-100®): A novel in-vitro system for evaluation of primary haemostasis in children
24. The determination of von Willebrand factor activity by collagen binding assay
25. Molecular mechanism and classification of von Willebrand disease
26. Von Willebrand's disease in Sweden
27. Spectrum of von Willebrand's disease: A study of 100 cases
28. Platelet von Willebrand factor: An important determinant of bleeding time in type 1 von Willebrand's disease
29. Evaluation of platelet function by PFA-100(TM)
30. Description of an in vitro platelet function analyzer - PFA-100(TM)
31. Characterization of an in vitro platelet function analyzer, PFA-100(TM)
32. Preliminary data from a field trial of the PFA-100(TM) system
33. PFA-100(TM) system: A new method for assessment of platelet dysfunction
34. A comparison of the effects of aspirin on bleeding time measured using Simplate(TM) methods and closure time measured using the PFA-100(TM), in healthy volunteers
35. Performance of the platelet function analyser PFA-100® in testing abnormalities of primary haemostasis
36. Ultrastructural analysis of the distribution of von Willebrand factor and fibrinogen in platelet aggregates formed in the PFA-100(TM)
37. Therapeutic monitoring of von Willebrand disease: Interest and limits of a platelet function analyser at high shear rates
38. Use of the PFA-100® in the assessment of primary, platelet-related hemostasis in a pediatric setting
39. Von Willebrand factor: Molecular size and functional activity
40. Laboratory assessment for von Willebrand disease: Comparison of functional assays and influence on the diagnosis
41. Usefulness of a functional test based on the von Willebrand factor-collagen binding to classify von Willebrand patients